Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pileri

Showing results (871-880 of 992) with videos related to

Pageof 100
Sort By:
Haematologica|November 8, 2011
Salvage treatment with lenalidomide and dexamethasone in relapsed/refractory mantle cell lymphoma: clinical results and effects on microenvironment and neo-angiogenic biomarkersFrancesco Zaja, Stefano De Luca, Umberto Vitolo, et al.
British Journal of Haematology|December 24, 2021
Prognostic impact of TP53 mutation in newly diagnosed diffuse large B-cell lymphoma patients treated in the FIL-DLCL04 trialAnnalisa Chiappella, Fary Diop, Claudio Agostinelli, et al.
The Journal of Investigative Dermatology|November 9, 2020
Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary SyndromePietro Quaglino, Paolo Fava, Alessandro Pileri, et al.
Blood|January 20, 2011
Gene expression analysis uncovers similarity and differences among Burkitt lymphoma subtypesPier Paolo Piccaluga, Giulia De Falco, Manjunath Kustagi, et al.
Blood|August 24, 2006
Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: Impact on WHO classificationLaura Pasqualucci, Arcangelo Liso, Maria Paola Martelli, et al.
Oncotarget|December 10, 2017
TCTN2: a novel tumor marker with oncogenic propertiesDavid Cano-Rodriguez, Susanna Campagnoli, Alberto Grandi, et al.
European Journal of Cancer (Oxford, England : 1990)|July 18, 2016
miRNA expression profiling divides follicular dendritic cell sarcomas into two groups, related to fibroblasts and myopericytomas or Castleman's diseaseSylvia Hartmann, Claudia Döring, Claudio Agostinelli, et al.
Blood|August 12, 2009
Hairy cell leukemias with unmutated IGHV genes define the minor subset refractory to single-agent cladribine and with more aggressive behaviorFrancesco Forconi, Elisa Sozzi, Emanuele Cencini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2010
Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasmsRoberto Piva, Luca Agnelli, Elisa Pellegrino, et al.
Italian Journal of Dermatology and Venereology|October 3, 2025
Dermatological adverse events during hematological and oncological therapies (Bruton's tyrosine kinase inhibitors and mogamulizumab): an Italian retrospective multicenter studyMichela Starace, Stephano Cedirian, Luca Rapparini, et al.
Pageof 100

Showing results (871-880 of 992) with videos related to

Sort By:
Pageof 100
Haematologica|November 8, 2011
Salvage treatment with lenalidomide and dexamethasone in relapsed/refractory mantle cell lymphoma: clinical results and effects on microenvironment and neo-angiogenic biomarkersFrancesco Zaja, Stefano De Luca, Umberto Vitolo, et al.
British Journal of Haematology|December 24, 2021
Prognostic impact of TP53 mutation in newly diagnosed diffuse large B-cell lymphoma patients treated in the FIL-DLCL04 trialAnnalisa Chiappella, Fary Diop, Claudio Agostinelli, et al.
The Journal of Investigative Dermatology|November 9, 2020
Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary SyndromePietro Quaglino, Paolo Fava, Alessandro Pileri, et al.
Blood|January 20, 2011
Gene expression analysis uncovers similarity and differences among Burkitt lymphoma subtypesPier Paolo Piccaluga, Giulia De Falco, Manjunath Kustagi, et al.
Blood|August 24, 2006
Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: Impact on WHO classificationLaura Pasqualucci, Arcangelo Liso, Maria Paola Martelli, et al.
Oncotarget|December 10, 2017
TCTN2: a novel tumor marker with oncogenic propertiesDavid Cano-Rodriguez, Susanna Campagnoli, Alberto Grandi, et al.
European Journal of Cancer (Oxford, England : 1990)|July 18, 2016
miRNA expression profiling divides follicular dendritic cell sarcomas into two groups, related to fibroblasts and myopericytomas or Castleman's diseaseSylvia Hartmann, Claudia Döring, Claudio Agostinelli, et al.
Blood|August 12, 2009
Hairy cell leukemias with unmutated IGHV genes define the minor subset refractory to single-agent cladribine and with more aggressive behaviorFrancesco Forconi, Elisa Sozzi, Emanuele Cencini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2010
Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasmsRoberto Piva, Luca Agnelli, Elisa Pellegrino, et al.
Italian Journal of Dermatology and Venereology|October 3, 2025
Dermatological adverse events during hematological and oncological therapies (Bruton's tyrosine kinase inhibitors and mogamulizumab): an Italian retrospective multicenter studyMichela Starace, Stephano Cedirian, Luca Rapparini, et al.
Pageof 100